Drug Therapy Aimed at Adenylyl Cyclase to Regulate Cyclic Nucleotide Signaling

E-ISSN： 2212-3873|6|3|239-247

ISSN： 1871-5303

Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.6, Iss.3, 2006-09, pp. : 239-247

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of SQ 22536, an adenylyl cyclase inhibitor, on isoproterenol-induced cyclic AMP elevation and relaxation in newborn ovine pulmonary veins

By Gao Y. Usha Raj J.

European Journal of Pharmacology, Vol. 436, Iss. 3, 2002-02 ,pp. : 227-233

Elsevier

Access to resources Recommend Favorite

Enhanced expression of Giα protein and adenylyl cyclase signaling in aortas from 1 kidney 1 clip hypertensive rats

By Garcia Raul Anand-Srivastava Madhu B. Ge Chang

Canadian Journal of Physiology and Pharmacology, Vol. 84, Iss. 7, 2006-07 ,pp. : 739-746

NRC Research Press

Access to resources Recommend Favorite

Ca 2+ -dependent sensitization of adenylyl cyclase activity

By Rousseau G. Haddad P.S. Gallo-Payet N. Bouvier M.

European Journal of Pharmacology, Vol. 422, Iss. 1, 2001-06 ,pp. : 53-60

Elsevier

Access to resources Recommend Favorite

Somatostatin coupling to adenylyl cyclase activity in the mouse retina

By Pavan Barbara Fiorini Sara Monte Massimo Lunghi Laura Biondi Carla Bagnoli Paola Cervia Davide

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 370, Iss. 2, 2004-08 ,pp. : 91-98

Springer Publishing Company

Access to resources Recommend Favorite

Inhibitors of cyclic nucleotide phosphodiesterase PDE3 as adjunct therapy for dilated cardiomyopathy

By Movsesian Matthew A Alharethi Rami

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 11, 2002-11 ,pp. : 1529-1536

Informa Healthcare

Access to resources Recommend Favorite